JNJ-247909290

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameJNJ-247909290
Drug Alias NameJNJ-247909290
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 2 antagonists
TargetsC-C chemokine receptor type 2
Therapy Area/IndicationsInflammationAutoimmune DiseasesObesity +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson Innovative MedicineJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson Innovative MedicineJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune DiseasesObesity +[4] 

Other Information

ATC CodeN/A
Related LinksN/A